RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재 SCOPUS SCIE

      Severe Hypoglycemia and Cardiovascular or All-Cause Mortality in Patients with Type 2 Diabetes

      한글로보기

      https://www.riss.kr/link?id=A103552354

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      Background: We investigated the association between severe hypoglycemia (SH) and the risk of cardiovascular (CV) or allcause mortality in patients with type 2 diabetes.
      Methods: The study included 1,260 patients aged 25 to 75 years with type 2 diabetes from the Vincent Type 2 Diabetes Resgistry (VDR), who consecutively enrolled (n=1,260) from January 2000 to December 2010 and were followed up until May 2015 with a median follow-up time of 10.4 years. Primary outcomes were death from any cause or CV death. We investigated the association between the CV or all-cause mortality and various covariates using Cox proportional hazards regression analysis.
      Results: Among the 906 participants (71.9%) who completed follow-up, 85 patients (9.4%) had at least one episode of SH, and 86 patients (9.5%) died (9.1 per 1,000 patient-years). Patients who had died were older, had a longer duration of diabetes and hypertension, received more insulin, and had more diabetic microvascular complications at baseline, as compared with surviving patients. The experience of SH was significantly associated with an increased risk of all-cause mortality (hazard ratio [HR], 2.64; 95% confidence interval [CI], 1.39 to 5.02; P=0.003) and CV mortality (HR, 6.34; 95% CI, 2.02 to 19.87; P=0.002) after adjusting for sex, age, diabetic duration, hypertension, mean glycosylated hemoglobin levels, diabetic nephropathy, lipid profiles, and insulin use.
      Conclusions: We found a strong association between SH and increased risk of all-cause and CV mortality in patients with type 2 diabetes.
      번역하기

      Background: We investigated the association between severe hypoglycemia (SH) and the risk of cardiovascular (CV) or allcause mortality in patients with type 2 diabetes. Methods: The study included 1,260 patients aged 25 to 75 years with type 2 diabete...

      Background: We investigated the association between severe hypoglycemia (SH) and the risk of cardiovascular (CV) or allcause mortality in patients with type 2 diabetes.
      Methods: The study included 1,260 patients aged 25 to 75 years with type 2 diabetes from the Vincent Type 2 Diabetes Resgistry (VDR), who consecutively enrolled (n=1,260) from January 2000 to December 2010 and were followed up until May 2015 with a median follow-up time of 10.4 years. Primary outcomes were death from any cause or CV death. We investigated the association between the CV or all-cause mortality and various covariates using Cox proportional hazards regression analysis.
      Results: Among the 906 participants (71.9%) who completed follow-up, 85 patients (9.4%) had at least one episode of SH, and 86 patients (9.5%) died (9.1 per 1,000 patient-years). Patients who had died were older, had a longer duration of diabetes and hypertension, received more insulin, and had more diabetic microvascular complications at baseline, as compared with surviving patients. The experience of SH was significantly associated with an increased risk of all-cause mortality (hazard ratio [HR], 2.64; 95% confidence interval [CI], 1.39 to 5.02; P=0.003) and CV mortality (HR, 6.34; 95% CI, 2.02 to 19.87; P=0.002) after adjusting for sex, age, diabetic duration, hypertension, mean glycosylated hemoglobin levels, diabetic nephropathy, lipid profiles, and insulin use.
      Conclusions: We found a strong association between SH and increased risk of all-cause and CV mortality in patients with type 2 diabetes.

      더보기

      참고문헌 (Reference)

      1 Bonds DE, "The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes:retrospective epidemiological analysis of the ACCORD study" 340 : b4909-, 2013

      2 Holstein A, "Substantial increase in incidence of severe hypoglycemia between 1997-2000 and 2007-2010: a German longitudinal population-based study" 35 : 972-975, 2012

      3 American Diabetes Association, "Standards of medical care in diabetes: 2014" 37 (37): S14-S80, 2014

      4 Hicks KA, "Standardized definitions for cardiovascular and stroke endpoint events in clinical trials"

      5 Kong AP, "Severe hypoglycemia identifies vulnerable patients with type 2 diabetes at risk for premature death and all-site cancer: the Hong Kong diabetes registry" 37 : 1024-1031, 2014

      6 Zoungas S, "Severe hypoglycemia and risks of vascular events and death" 363 : 1410-1418, 2010

      7 Fahrmann ER, "Severe hypoglycemia and coronary artery calcification during the diabetes control and complications trial/epidemiology of diabetes interventions and complications (DCCT/EDIC) study" 107 : 280-289, 2015

      8 Goto A, "Severe hypoglycaemia and cardiovascular disease: systematic review and meta-analysis with bias analysis" 347 : f4533-, 2013

      9 Stahn A, "Relationship between hypoglycemic episodes and ventricular arrhythmias in patients with type 2 diabetes and cardiovascular diseases: silent hypoglycemias and silent arrhythmias" 37 : 516-520, 2014

      10 Algra A, "QTc prolongation measured by standard 12-lead electrocardiography is an independent risk factor for sudden death due to cardiac arrest" 83 : 1888-1894, 1991

      1 Bonds DE, "The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes:retrospective epidemiological analysis of the ACCORD study" 340 : b4909-, 2013

      2 Holstein A, "Substantial increase in incidence of severe hypoglycemia between 1997-2000 and 2007-2010: a German longitudinal population-based study" 35 : 972-975, 2012

      3 American Diabetes Association, "Standards of medical care in diabetes: 2014" 37 (37): S14-S80, 2014

      4 Hicks KA, "Standardized definitions for cardiovascular and stroke endpoint events in clinical trials"

      5 Kong AP, "Severe hypoglycemia identifies vulnerable patients with type 2 diabetes at risk for premature death and all-site cancer: the Hong Kong diabetes registry" 37 : 1024-1031, 2014

      6 Zoungas S, "Severe hypoglycemia and risks of vascular events and death" 363 : 1410-1418, 2010

      7 Fahrmann ER, "Severe hypoglycemia and coronary artery calcification during the diabetes control and complications trial/epidemiology of diabetes interventions and complications (DCCT/EDIC) study" 107 : 280-289, 2015

      8 Goto A, "Severe hypoglycaemia and cardiovascular disease: systematic review and meta-analysis with bias analysis" 347 : f4533-, 2013

      9 Stahn A, "Relationship between hypoglycemic episodes and ventricular arrhythmias in patients with type 2 diabetes and cardiovascular diseases: silent hypoglycemias and silent arrhythmias" 37 : 516-520, 2014

      10 Algra A, "QTc prolongation measured by standard 12-lead electrocardiography is an independent risk factor for sudden death due to cardiac arrest" 83 : 1888-1894, 1991

      11 Grambsch PM, "Proportional hazards tests and diagnostics based on weighted residuals" 81 : 515-526, 1994

      12 Inzucchi SE, "Management of hyperglycaemia in type 2 diabetes: a patientcentered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)" 55 : 1577-1596, 2012

      13 김진택, "Increasing Trend in the Number of Severe Hypoglycemia Patients in Korea" 대한당뇨병학회 35 (35): 166-172, 2011

      14 Desouza CV, "Hypoglycemia, diabetes, and cardiovascular events" 33 : 1389-1394, 2010

      15 Frier BM, "Hypoglycemia and cardiovascular risks" 34 (34): S132-S137, 2011

      16 Cryer PE, "Hypoglycaemia: the limiting factor in the glycaemic management of type I and type II diabetes" 45 : 937-948, 2002

      17 Cox AJ, "Heart rate-corrected QT interval is an independent predictor of all-cause and cardiovascular mortality in individuals with type 2 diabetes: the Diabetes Heart Study" 37 : 1454-1461, 2014

      18 Action to Control Cardiovascular Risk in Diabetes Study Group, "Effects of intensive glucose lowering in type 2 diabetes" 358 : 2545-2559, 2008

      19 ORIGIN Trial Investigators, "Does hypoglycaemia increase the risk of cardiovascular events? A report from the ORIGIN trial" 34 : 3137-3144, 2013

      20 Vinik AI, "Diabetic autonomic neuropathy" 26 : 1553-1579, 2003

      21 Workgroup on Hypoglycemia, "Defining and reporting hypoglycemia in diabetes: a report from the American Diabetes Association Workgroup on Hypoglycemia" 28 : 1245-1249, 2005

      22 Koivisto VA, "Cardiovascular disease and its risk factors in IDDM in Europe. EURODIAB IDDM Complications Study Group" 19 : 689-697, 1996

      23 Yun JS, "Cardiovascular autonomic dysfunction predicts severe hypoglycemia in patients with type 2 diabetes: a 10-year follow-up study" 37 : 235-241, 2014

      24 윤재승, "Avoiding or coping with severe hypoglycemia in patients with type 2 diabetes" 대한내과학회 30 (30): 6-16, 2015

      25 Stratton IM, "Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study" 321 : 405-412, 2000

      26 Hsu PF, "Association of clinical symptomatic hypoglycemia with cardiovascular events and total mortality in type 2 diabetes: a nationwide population-based study" 36 : 894-900, 2013

      27 Bedenis R, "Association between severe hypoglycemia, adverse macrovascular events, and inflammation in the Edinburgh Type 2 Diabetes Study" 37 : 3301-3308, 2014

      28 Adler GK, "Antecedent hypoglycemia impairs autonomic cardiovascular function: implications for rigorous glycemic control" 58 : 360-366, 2009

      29 Levey AS, "A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group" 130 : 461-470, 1999

      30 고승현, "2011 Clinical Practice Guidelines for Type 2 Diabetes in Korea" 대한당뇨병학회 35 (35): 431-436, 2011

      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2023 평가예정 해외DB학술지평가 신청대상 (해외등재 학술지 평가)
      2020-01-01 평가 등재학술지 유지 (해외등재 학술지 평가) KCI등재
      2017-12-01 평가 SCIE 등재 (기타) KCI등재
      2011-05-30 학술지명변경 한글명 : KOREAN DIABETES JOURNAL -> Diabetes and Metabolism Journal KCI등재
      2011-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2009-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2006-01-01 평가 등재학술지 선정 (등재후보2차) KCI등재
      2005-01-01 평가 등재후보 1차 PASS (등재후보1차) KCI등재후보
      2004-01-01 평가 등재후보학술지 유지 (등재후보1차) KCI등재후보
      2003-01-01 평가 등재후보학술지 유지 (등재후보1차) KCI등재후보
      2002-01-01 평가 등재후보학술지 유지 (등재후보1차) KCI등재후보
      2000-07-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 0.55 0.55 0.55
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      0.49 0.5 1.018 0.21
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼